Leishmania (Sauroleishmania) tarentolae versus pathogenic species: comparative evaluation of protease activity, glycoconjugates, resistance to complement and metabolome composition.

Autor: Andrade FFD; Universidade Federal de Minas Gerais, Instituto de Ciências Biológicas, Departamento de Biologia Geral, Belo Horizonte, MG, Brasil., Vitório JG; Universidade Federal de Minas Gerais, Faculdade de Farmácia, Departamento de Análises Clínicas e Toxicológicas, Belo Horizonte, MG, Brasil., Canuto GAB; Universidade Federal da Bahia, Instituto de Química, Departamento de Química Analítica, Salvador, BA, Brasil., Nunes FFC; Universidade Federal de Minas Gerais, Faculdade de Farmácia, Departamento de Análises Clínicas e Toxicológicas, Belo Horizonte, MG, Brasil., Rodrigues IA; Universidade Federal de Minas Gerais, Faculdade de Farmácia, Departamento de Análises Clínicas e Toxicológicas, Belo Horizonte, MG, Brasil., Almeida APMM; Universidade Federal de Minas Gerais, Faculdade de Farmácia, Departamento de Análises Clínicas e Toxicológicas, Belo Horizonte, MG, Brasil., Nascimento FC; Universidade Federal de Minas Gerais, Faculdade de Farmácia, Departamento de Análises Clínicas e Toxicológicas, Belo Horizonte, MG, Brasil., Costa AO; Universidade Federal de Minas Gerais, Faculdade de Farmácia, Departamento de Análises Clínicas e Toxicológicas, Belo Horizonte, MG, Brasil., Vieira TDS; Fundação Oswaldo Cruz-Fiocruz, Instituto René Rachou, Grupo Biotecnologia Aplicada ao Estudo de Patógenos, Belo Horizonte, MG, Brasil., Silva ACC; Universidade Federal de Minas Gerais, Instituto de Ciências Biológicas, Departamento de Biologia Geral, Belo Horizonte, MG, Brasil., André LC; Universidade Federal de Minas Gerais, Faculdade de Farmácia, Departamento de Análises Clínicas e Toxicológicas, Belo Horizonte, MG, Brasil., Gontijo CMF; Fundação Oswaldo Cruz-Fiocruz, Instituto René Rachou, Grupo Biotecnologia Aplicada ao Estudo de Patógenos, Belo Horizonte, MG, Brasil., Junqueira C; Fundação Oswaldo Cruz-Fiocruz, Instituto René Rachou, Grupo Biotecnologia Aplicada ao Estudo de Patógenos, Belo Horizonte, MG, Brasil., Toledo JS; Universidade Federal de Minas Gerais, Faculdade de Farmácia, Departamento de Análises Clínicas e Toxicológicas, Belo Horizonte, MG, Brasil., Fernandes AP; Universidade Federal de Minas Gerais, Instituto de Ciências Biológicas, Departamento de Biologia Geral, Belo Horizonte, MG, Brasil., Soares RP; Fundação Oswaldo Cruz-Fiocruz, Instituto René Rachou, Grupo Biotecnologia Aplicada ao Estudo de Patógenos, Belo Horizonte, MG, Brasil.

Publikováno v: Memorias do Instituto Oswaldo Cruz [Mem Inst Oswaldo Cruz] 2024 May 20; Vol. 119, pp. e230243. Date of Electronic Publication: 2024 May 20 (Print Publication: 2024).

Gasdermin D permeabilization of mitochondrial inner and outer membranes accelerates and enhances pyroptosis.

Autor: Miao R; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA. Electronic address: rui.miao@childrens.harvard.edu., Jiang C; Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China; Key Laboratory of RNA Science and Engineering, Shanghai Institute of Immunity and Infection, Chinese Academy of Sciences, Shanghai 200031, China., Chang WY; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA., Zhang H; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA., An J; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA., Ho F; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA., Chen P; Key Laboratory of RNA Science and Engineering, Shanghai Institute of Immunity and Infection, Chinese Academy of Sciences, Shanghai 200031, China., Zhang H; Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China; Key Laboratory of RNA Science and Engineering, Shanghai Institute of Immunity and Infection, Chinese Academy of Sciences, Shanghai 200031, China., Junqueira C; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA; Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, MG 30190-009, Brazil., Amgalan D; Departments of Medicine and Cell Biology, Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA., Liang FG; Departments of Medicine and Cell Biology, Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA., Zhang J; Center for Cancer Research, Massachusetts General Hospital and Department of Medicine, Harvard Medical School, Boston, MA 02129, USA., Evavold CL; Ragon Institute of Mass General, MIT and Harvard, Cambridge, MA 02139, USA., Hafner-Bratkovič I; Division of Gastroenterology, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA; Department of Synthetic Biology and Immunology, National Institute of Chemistry and EN-FIST Centre of Excellence and Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia., Zhang Z; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Fontana P; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA., Xia S; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA., Waldeck-Weiermair M; Brigham and Women's Hospital, Department of Medicine, Cardiovascular Division, Harvard Medical School, Boston, MA 02115, USA., Pan Y; Department of Dermatology and Harvard Skin Disease Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA., Michel T; Brigham and Women's Hospital, Department of Medicine, Cardiovascular Division, Harvard Medical School, Boston, MA 02115, USA., Bar-Peled L; Center for Cancer Research, Massachusetts General Hospital and Department of Medicine, Harvard Medical School, Boston, MA 02129, USA., Wu H; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA., Kagan JC; Division of Gastroenterology, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA., Kitsis RN; Departments of Medicine and Cell Biology, Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA., Zhang P; Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China. Electronic address: zhangpeng1121@tongji.edu.cn., Liu X; Key Laboratory of RNA Science and Engineering, Shanghai Institute of Immunity and Infection, Chinese Academy of Sciences, Shanghai 200031, China. Electronic address: xingliu@ips.ac.cn., Lieberman J; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA. Electronic address: judy.lieberman@childrens.harvard.edu.

Publikováno v: Immunity [Immunity] 2023 Nov 14; Vol. 56 (11), pp. 2523-2541.e8. Date of Electronic Publication: 2023 Nov 03.

Accumulation of Neutrophil Phagocytic Antibody Features Tracks With Naturally Acquired Immunity Against Malaria in Children.

Autor: Nziza N; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, USA., Tran TM; Malaria Infection Biology and Immunity Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.; Division of Infectious Diseases, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.; Ryan White Center for Pediatric Infectious Disease and Global Health, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA., DeRiso EA; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, USA., Dolatshahi S; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, USA., Herman JD; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, USA., de Lacerda L; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.; Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, MG, Brazil., Junqueira C; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.; Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, MG, Brazil., Lieberman J; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA., Ongoiba A; Malaria Research and Training Centre, Mali International Center of Excellence in Research, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali., Doumbo S; Malaria Research and Training Centre, Mali International Center of Excellence in Research, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali., Kayentao K; Malaria Research and Training Centre, Mali International Center of Excellence in Research, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali., Traore B; Malaria Research and Training Centre, Mali International Center of Excellence in Research, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali., Crompton PD; Malaria Infection Biology and Immunity Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA., Alter G; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, USA.

Publikováno v: The Journal of infectious diseases [J Infect Dis] 2023 Sep 15; Vol. 228 (6), pp. 759-768.

Use of active films in the minimally processed potato conservation / Uso de filmes ativos na conservação de batata minimamente processada

Autor: Maria Paula Junqueira C. Gonçalves, Edimar Aparecida Filomeno Fontes, Soraia Vilela Borges, Danielle Augusta Alvarenga dos Santos, Nilda de Fátima Ferreira Soares, Érika Endo

Publikováno v: Semina: Ciências Agrárias, Vol 29, Iss 2, Pp 349-360 (2008)

Potatoes of the variety “Monalisa” were minimally processed like slices and submitted to different treatments, employed to decrease the enzymatic browning and growth of microorganisms. These treatments consisted on pure cellulose films (FP) or in

Externí odkaz: https://doaj.org/article/fe0518c39c9543e7976fa81169e10c06

ASP-2/Trans-sialidase chimeric protein induces robust protective immunity in experimental models of Chagas' disease.

Autor: Castro JT; Centro de Tecnologia em Vacinas, Universidade Federal de Minas Gerais, Parque Tecnológico de Belo Horizonte, Belo Horizonte, Brazil.; Centro de Pesquisas Rene Rachou, Fundação Osvaldo Cruz, Rio de Janeiro, Brazil.; Plataforma de Medicina Translacional, Fundação Oswaldo Cruz-Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, São Paulo, Brazil., Brito R; Universidade Federal de Ouro Preto, Ouro Preto, Brazil., Hojo-Souza NS; Centro de Tecnologia em Vacinas, Universidade Federal de Minas Gerais, Parque Tecnológico de Belo Horizonte, Belo Horizonte, Brazil.; Centro de Pesquisas Rene Rachou, Fundação Osvaldo Cruz, Rio de Janeiro, Brazil., Azevedo B; Centro de Pesquisas Rene Rachou, Fundação Osvaldo Cruz, Rio de Janeiro, Brazil., Salazar N; Centro de Tecnologia em Vacinas, Universidade Federal de Minas Gerais, Parque Tecnológico de Belo Horizonte, Belo Horizonte, Brazil., Ferreira CP; Universidade Federal de São Paulo, São Paulo, Brazil., Junqueira C; Centro de Tecnologia em Vacinas, Universidade Federal de Minas Gerais, Parque Tecnológico de Belo Horizonte, Belo Horizonte, Brazil.; Centro de Pesquisas Rene Rachou, Fundação Osvaldo Cruz, Rio de Janeiro, Brazil., Fernandes AP; Centro de Tecnologia em Vacinas, Universidade Federal de Minas Gerais, Parque Tecnológico de Belo Horizonte, Belo Horizonte, Brazil., Vasconcellos R; Universidade Federal de São Paulo, São Paulo, Brazil., Cardoso JM; Universidade Federal de Ouro Preto, Ouro Preto, Brazil., Aguiar-Soares RDO; Universidade Federal de Ouro Preto, Ouro Preto, Brazil., Vieira PMA; Universidade Federal de Ouro Preto, Ouro Preto, Brazil., Carneiro CM; Universidade Federal de Ouro Preto, Ouro Preto, Brazil., Valiate B; Centro de Tecnologia em Vacinas, Universidade Federal de Minas Gerais, Parque Tecnológico de Belo Horizonte, Belo Horizonte, Brazil.; Centro de Pesquisas Rene Rachou, Fundação Osvaldo Cruz, Rio de Janeiro, Brazil., Toledo C; Centro de Pesquisas Rene Rachou, Fundação Osvaldo Cruz, Rio de Janeiro, Brazil., Salazar AM; Oncovir, Inc, Washington, USA., Caballero O; Orygen, LTDA, Sao Paulo, Brazil., Lannes-Vieira J; Fundação Osvaldo Cruz, Rio de Janeiro, Brazil., Teixeira SR; Centro de Tecnologia em Vacinas, Universidade Federal de Minas Gerais, Parque Tecnológico de Belo Horizonte, Belo Horizonte, Brazil., Reis AB; Universidade Federal de Ouro Preto, Ouro Preto, Brazil., Gazzinelli RT; Centro de Tecnologia em Vacinas, Universidade Federal de Minas Gerais, Parque Tecnológico de Belo Horizonte, Belo Horizonte, Brazil. ricardo.gazzinelli@fiocruz.br.; Centro de Pesquisas Rene Rachou, Fundação Osvaldo Cruz, Rio de Janeiro, Brazil. ricardo.gazzinelli@fiocruz.br.; Plataforma de Medicina Translacional, Fundação Oswaldo Cruz-Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, São Paulo, Brazil. ricardo.gazzinelli@fiocruz.br.

Publikováno v: NPJ vaccines [NPJ Vaccines] 2023 May 31; Vol. 8 (1), pp. 81. Date of Electronic Publication: 2023 May 31.